A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services
- PMID: 17102813
- PMCID: PMC2360609
- DOI: 10.1038/sj.bjc.6603451
A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services
Abstract
To determine which aspects of breast cancer genetic counselling are important to Ashkenazi Jewish women, a discrete choice experiment was conducted. Participants consisted of 339 Australian Ashkenazi Jewish women who provided a blood sample for research used to test for Ashkenazi Jewish ancestral mutations in the genes BRCA1 and BRCA2, and were offered their genetic test result through a cancer genetics service. Main outcome measures were women's preferences for, and trade-offs between, the genetic counselling aspects of providing cancer, gene, and risk information (information); giving advice about cancer surveillance (surveillance); preparing for genetic testing (preparation); and, assistance with decision-making (direction). Respondents most valued information, about twice as much as advice about surveillance, four times as much as preparation for testing, and nine times as much as assistance with decision-making, which was least valued. Women's preferences were consistent with the major goals of genetic counselling, which include providing information and surveillance advice, and avoiding direction by facilitating autonomous decision-making. There were differences between the women in which aspects they most favoured, suggesting that counselling that elicits and responds to clients' preferences is more likely to meet clients' needs.
Figures
Similar articles
-
Determinants of preferences for genetic counselling in Jewish women.Fam Cancer. 2006;5(2):159-67. doi: 10.1007/s10689-005-3871-7. Fam Cancer. 2006. PMID: 16736286
-
A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.Genet Med. 2002 Sep-Oct;4(5):346-52. doi: 10.1097/00125817-200209000-00005. Genet Med. 2002. PMID: 12394347
-
Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.Clin Genet. 2010 Nov;78(5):411-7. doi: 10.1111/j.1399-0004.2010.01499.x. Epub 2010 Jul 28. Clin Genet. 2010. PMID: 20653694
-
Ethical issues related to BRCA gene testing in orthodox Jewish women.Nurs Ethics. 2008 Jul;15(4):512-22. doi: 10.1177/09697330080150041201. Nurs Ethics. 2008. PMID: 18515440 Review.
-
Hereditary breast cancer in Jews.Fam Cancer. 2004;3(3-4):249-57. doi: 10.1007/s10689-004-9550-2. Fam Cancer. 2004. PMID: 15516849 Review.
Cited by
-
Valuing Preferences for the Process and Outcomes of Clinical Genetics Services: A Pilot Study.Patient. 2016 Apr;9(2):135-47. doi: 10.1007/s40271-015-0133-0. Patient. 2016. PMID: 26085127
-
Focusing on patient needs and preferences may improve genetic counseling for colorectal cancer.J Genet Couns. 2013 Feb;22(1):118-24. doi: 10.1007/s10897-012-9519-5. Epub 2012 Aug 23. J Genet Couns. 2013. PMID: 22914993 Free PMC article.
-
Cancer Survivor Preferences for Models of Breast Cancer Follow-Up Care: Selecting Attributes for Inclusion in a Discrete Choice Experiment.Patient. 2023 Jul;16(4):371-383. doi: 10.1007/s40271-023-00631-0. Epub 2023 May 22. Patient. 2023. PMID: 37213062 Free PMC article.
-
Women's preferences, willingness-to-pay, and predicted uptake for single-nucleotide polymorphism gene testing to guide personalized breast cancer screening strategies: a discrete choice experiment.Patient Prefer Adherence. 2018 Sep 18;12:1837-1852. doi: 10.2147/PPA.S171348. eCollection 2018. Patient Prefer Adherence. 2018. PMID: 30271127 Free PMC article.
-
Personalized genomic results: analysis of informational needs.J Genet Couns. 2014 Aug;23(4):578-87. doi: 10.1007/s10897-014-9693-8. Epub 2014 Feb 3. J Genet Couns. 2014. PMID: 24488620
References
-
- Apicella C, Andrews L, Hodgson SV, Fisher SA, Lewis CM, Solomon E, Tucker K, Friedlander M, Bankier A, Southey MC, Venter DJ, Hopper JL (2003) Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a defined personal and family history in an Ashkenazi Jewish woman (LAMBDA). Breast Cancer Res 5: R206–R216, doi:10.1186/bcr644 - PMC - PubMed
-
- Apicella C, Peacock S, Andrews L, Tucker K, Bankier A, Daly MB, Hopper JL (2006) Determinants of preferences for genetic counselling in Jewish Women. Fam Cancer 5: 159–167, doi:10.1007/s10689-005-3871-7 - PubMed
-
- Berkenstadt M, Shiloh S, Barkai G, Katznelson MB, Goldman B (1999) Perceived personal control (PPC): a new concept in measuring outcome of genetic counseling. Am J Med Genet 82: 53–59, doi:10.1002/(SICI)1096-8628(19990101)82:1 - PubMed
-
- Bernhardt BA, Biesecker BB, Mastromarino CL (2000) Goals, benefits, and outcomes of genetic counseling: client and genetic counselor assessment. Am J Med Genet 94: 189–197 - PubMed
-
- Bradley M (1991) User's Manual for SPEED Version 2.1 Stated Preference Experiment Editor and Designer. Hague: Hague Consulting Group
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous